Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 470-475

  Nakayama, Hitomi ^a   Otabe, Shuichi ^a   Ueno, Takato ^b   Hirota, Naotoshi ^a   Yuan, Xiaohong ^a   Fukutani, Tomoka ^a   Hashinaga, Toshihiko ^a   Wada, Nobuhiko ^a   Yamada, Kentaro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL INFILTRATION; CELL NUCLEUS; CONTROLLED STUDY; DISEASE SEVERITY; FATTY LIVER; FIBROSIS; HYPERGLYCEMIA; IMMUNITY; INSULIN RESISTANCE; LIVER HISTOLOGY; MALLORY BODY; MONONUCLEAR CELL; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CELL NUCLEUS; DNA PRIMERS; FATTY LIVER; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; MICE; MICE, TRANSGENIC; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 33947264902     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.11.004     Document Type: Article

References (30)

1. Ludwig J., Viggiano T.R., McGill D.B., et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55 (1980) 434-438
2. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
3. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
5. Willner I.R., Waters B., Patil S.R., et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (2001) 2957-2961
6. Pagano G., Pacini G., Musso G., et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35 (2002) 367-372
7. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35 (2002) 373-379
8. García-Monzón C., Martín-Pérez E., Iacono O.L., et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33 (2000) 716-724
9. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 (2001) 91-100
10. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
11. Huseman C., Johanson A., Varma M., et al. Congenital lipodystrophy: an endocrine study in three siblings. I. Disorders of carbohydrate metabolism. J Pediatr 93 (1978) 221-226
12. Magre J., Reynet C., Capeau J., et al. In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Evidence for heterogeneous postbinding defects. Diabetes 37 (1988) 421-428
13. Robert J.J., Rakotoambinina B., Cochet I., et al. The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes. Diabetologia 36 (1993) 1288-1292
14. Pardini V.C., Victoria I.M., Rocha S.M., et al. Leptin levels, beta-cell function, and insulin sensitivity in families with congenital and acquired generalized lipoatropic diabetes. J Clin Endocrinol Metab 83 (1998) 503-508
15. de Craemer D., Van Maldergem L., and Roels F. Hepatic ultrastructure in congenital total lipodystrophy with special reference to peroxisomes. Ultrastruct Pathol 16 (1992) 307-316
16. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11 (1990) 74-80
17. Yokoyama C., Wang X., Briggs M.R., et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low-density lipoprotein receptor gene. Cell 75 (1993) 187-197
18. Wang X., Sato R., Brown M.S., et al. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77 (1994) 53-62
19. Shimomura I., Hammer R.E., Richardson J.A., et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12 (1998) 3182-3194
20. Nishioka N., and Arnold S.E. Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 12 (2004) 167-175
21. Weltman M.D., Farrell G.C., and Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111 (1996) 1645-1653
22. Zhang B.H., Weltman M., and Farrell G.C. Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 14 (1999) 133-137
23. Leclercq I.A., Farrell G.C., Field J., et al. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105 (2000) 1067-1075
24. Kirsch R., Clarkson V., Shephard E.G., et al. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. J Gastroenterol Hepatol 18 (2003) 1272-1282
25. Yoshimatsu M., Terasaki Y., Sakashita N., et al. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process. Int J Exp Pathol 85 (2004) 335-343
26. Shiota G. Loss of function of retinoic acid in liver leads to steatohepatitis and liver tumor: a NASH animal model. Hepatol Res (2005) 30 [electronic publication ahead of print]
27. Parola M., and Novo E. Nrf1 gene expression in the liver: a single gene linking oxidative stress to NAFLD, NASH and hepatic tumours. J Hepatol 43 (2005) 1096-1097
28. Yang S.Q., Lin H.Z., Lane M.D., et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94 (1997) 2557-2562
29. Ikejima K., Okumura K., Tie L., et al. The role of leptin in progression of non-alcoholic fatty liver disease. Hepatol Res 33 (2005) 151-154
30. Atul S., Padmini M., Xiaomin P., et al. Obese and diabetic db/db mice develop marked liver fibrosis in model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287 (2004) 1035-1043